Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults

Obesity

Volumn 21, Issue 1, 2013, Pages 93-100

  Braun, Barry ^a   Malin, Steven K ^a   Nightingale, Joy ^a   Choi, Sung Eun ^b   Chipkin, Stuart R ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; FITNESS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN CONSUMPTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADIPOSITY; ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; GLUCOSE INTOLERANCE; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METABOLIC SYNDROME X; METFORMIN; MIDDLE AGED; OBESITY; RESISTANCE TRAINING; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84876293806     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.133     Document Type: Article

References (40)

1. Blake DR, Meigs JB, Muller DC et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004;53: 2095-2100. (Pubitemid 38970760)
2. Festa A, D'Agostino R, Howard G, Mykknen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. (Pubitemid 30430551)
3. Orchard TJ, Temprosa M, Goldberg R et al.; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142:611-619. (Pubitemid 40529957)
4. Haffner S. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;92:18J-26J.
5. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-723. (Pubitemid 35013848)
6. Houmard JA, Tanner CJ, Slentz CA et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 2004;96:101-106. (Pubitemid 38031988)
7. Dela F, Larsen JJ, Mikines KJ et al. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 1995;44: 1010-1020.
8. Holten MK, Zacho M, Gaster M et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004;53:294-305. (Pubitemid 38174543)
9. Durstine JL, Grandjean PW, Cox CA, Thompson PD. Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil 2002;22:385-398. (Pubitemid 35403593)
10. Herder C, Peltonen M, Koenig W et al.; Finnish Diabetes Prevention Study Group. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009;52:433-442.
11. Bacon SL, Sherwood A, Hinderliter A, Blumenthal JA. Effects of exercise, diet and weight loss on high blood pressure. Sports Med 2004;34:307-316. (Pubitemid 38680203)
12. Musi N, Hirshman MF, Nygren J et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002; 51:2074-2081. (Pubitemid 34729010)
13. Lehtovirta M, Forsen B, Gullström M et al. Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med 2001;18:578-583. (Pubitemid 32823083)
14. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996;81:4059-4067. (Pubitemid 26380418)
15. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 1991;73: 1294-1301. (Pubitemid 121000706)
16. Rhee MK, Herrick K, Ziemer DC et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33:49-54.
17. Driscoll SD, Meininger GE, Lareau MT et al. Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004;18:465-473. (Pubitemid 38365874)
18. Andreadis EA, Katsanou PM, Georgiopoulos DX et al. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects-the Carmos study. Exp Clin Endocrinol Diabetes 2009;117:175-180.
19. Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 2012;35:131-136.
20. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
21. Johnson JL, Slentz CA, Houmard JA et al. Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 2007;100:1759-1766. (Pubitemid 350234795)
22. Fleiss JL. Statistical Methods for Rates and Proportions. John Wiley: New York, 1981, pp 114.
23. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215-224.
24. Church TS, Martin CK, Thompson AM et al. Changes in weight, waist circumference and compensatory responses with different doses of exercise among sedentary, overweight postmenopausal women. PLoS ONE 2009;4:e4515.
25. Donnelly JE, Hill JO, Jacobsen DJ et al. Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial. Arch Intern Med 2003;163:1343-1350. (Pubitemid 36676200)
26. Clarson CL, Mahmud FH, Baker JE et al. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine 2009;36:141-146.
27. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr 2008;152:817-822.
28. Atabek ME, Pirgon O. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial. J Pediatr Endocrinol Metab 2008;21:339-348. (Pubitemid 351802726)
29. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 1991;229:181-187.
30. Giugliano D, De Rosa N, Di Maro G et al. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care 1993;16:1387-1390.
31. Dorella M, Giusto M, Da Tos V et al. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance. J Clin Endocrinol Metab 1996;81: 1568-1574. (Pubitemid 26118594)
32. Braun B, Eze P, Stephens BR et al. Impact of metformin on peak aerobic capacity. Appl Physiol Nutr Metab 2008;33:61-67.
33. Verma S, Wang CH, Li SH et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002;106: 913-919. (Pubitemid 34925323)
34. Lira VA, Brown DL, Lira AK et al. Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells. J Physiol (Lond) 2010;588:3551-3566.
35. Sharoff CG, Hagobian TA, Malin SK et al. Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am J Physiol Endocrinol Metab 2010;298:E815-E823.
36. Kraus WE, Slentz CA. Exercise training, lipid regulation, and insulin action: a tangled web of cause and effect. Obesity (Silver Spring) 2009;17 Suppl 3: S21-S26.
37. Smith AC, Mullen KL, Junkin KA et al. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab 2007;293: E172-E181. (Pubitemid 47105931)
38. Iozzo P, Hallsten K, Oikonen V et al. Effects ofmetformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. Diabetes Care 2003;26:2069-2074. (Pubitemid 41184254)
39. Koh HJ, Hirshman MF, He H et al. Adrenaline is a critical mediator of acute exercise- induced AMP-activated protein kinase activation in adipocytes. Biochem J 2007;403:473-481. (Pubitemid 46706975)
40. Slentz CA, Houmard JA, Johnson JL et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 2007;103:432-442. (Pubitemid 47204960)